GlycoMimetics, Inc. Competitors
| Symbol | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|
ACHL
Achilles Therapeutics plc |
$1.17 | $37.06 M | -0.56 | 204 | $0 |
ANTX
AN2 Therapeutics, Inc. |
$1.22 | $60.55 M | -0.81 | 41 | $0 |
ASMB
Assembly Biosciences, Inc. |
$14.60 | $78.73 M | -1.35 | 65 | $7.16 M |
BCAB
BioAtla, Inc. |
$0.50 | $73.14 M | -0.61 | 65 | $0 |
CUE
Cue Biopharma, Inc. |
$1.21 | $71.99 M | -1.38 | 53 | $5.49 M |
DYN
Dyne Therapeutics, Inc. |
$14.99 | $3.03 B | -7.77 | 173 | $0 |
FHTX
Foghorn Therapeutics Inc. |
$4.26 | $332.53 M | -2.73 | 116 | $34.16 M |
IVA
Inventiva S.A. |
$2.11 | $185.39 M | -1.34 | 123 | $17.48 M |
LIFE
aTyr Pharma, Inc. |
$1.90 | $131.12 M | -2.16 | 56 | $353,000 |
MLYS
Mineralys Therapeutics, Inc. |
$9.09 | $652.38 M | -6.03 | 28 | $0 |
NLTX
Neoleukin Therapeutics, Inc. |
$3.49 | $8.20 M | -0.28 | 7 | $0 |
SPRO
Spero Therapeutics, Inc. |
$0.97 | $75.85 M | 3.19 | 46 | $96.74 M |
TIL
Instil Bio, Inc. |
$20.19 | $69.59 M | -0.56 | 49 | $0 |
TRVI
Trevi Therapeutics, Inc. |
$3.94 | $171.86 M | -7.18 | 27 | $0 |